There’s No Getting Around Prothena Corporation plc (NASDAQ: PRTA) Success

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. The stock was recently discussed on Yahoo Finance as it revealed that Prothena to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Stocks Info

Prothena Corporation plc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. At the end of the last regular session, the stock closed at $28.38 and fluctuated between $28.65 as its day high and $27.55 as its day low. The current market capitalization of Prothena Corporation plc is $1.52B. A total of 1.02 million shares were traded on the day, compared to an average of 1.19 shares.

Insider Activity

Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, PRTA has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 46 BUYs and 98 SELLs from insiders. Insiders purchased 408,333 shares during that period but sold 408,333.

In the most recent transaction, Walker Karin L sold 5,000 shares of PRTA for 34.00 per share on Jan 24. After the transaction, the Chief Accounting Officer now owns 0 company shares. In a previous transaction on Dec 20, Walker Karin L sold 5,000 shares at 37.19 per share. PRTA shares that Chief Accounting Officer owns now total 0.

Among the insiders who sold shares, Walker Karin L disposed of 5,000 shares on Nov 30 at a per-share price of $34.00. This resulted in the Chief Accounting Officer holding 0 shares of PRTA after the transaction. In another insider transaction, Walker Karin L sold 5,000 shares at $41.04 per share on Oct 25. Company shares held by the Chief Accounting Officer now total 0.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for PRTA in the last 3 months, the mean price target is $75.09 with high estimates of $100.00 and low estimates of $36.00. In terms of 52-week highs and lows, PRTA has a high of $79.65 and a low of $24.28.

As of this writing, PRTA has an earnings estimate of $Prothena Corporation plc per share for the current quarter. EPS was calculated based on a consensus of, Inc. estimates, with a high estimate of $Privia Health Group, Inc. per share and a lower estimate of $PermRock Royalty Trust Trust.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. PRTA’s latest balance sheet shows that the firm has $579.09M in Cash & Short Term Investments as of fiscal 2021. There were $12.33M in debt and $33.45M in liabilities at the time. Its Book Value Per Share was $11.51, while its Total Shareholder’s Equity was $466.04M.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PRTA is Buy with a score of 4.60.

Most Popular

Related Posts